First Header Logo Second Header Logo

Connection

Thomas Wierzba to Dose-Response Relationship, Immunologic

Back to Details
This is a "connection" page, showing publications Thomas Wierzba has written about Dose-Response Relationship, Immunologic.
Thomas Wierzba
Connection Strength
0.042
Dose-Response Relationship, Immunologic
  1. Raqib R, Sarker P, Zaman K, Alam NH, Wierzba TF, Maier N, Talukder K, Baqui AH, Suvarnapunya AE, Qadri F, Walker RI, Fix A, Venkatesan MM. A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children. Hum Vaccin Immunother. 2019; 15(6):1326-1337.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.